Sox9 regulates hyperexpression of Wnt1 and Fzd1 in human osteosarcoma tissues and cells.

Osteosarcoma (OS) is the most common primary malignant bone tumor that has poor prognosis. Molecular mechanisms underlying disease progression remain largely unknown. Sox9, one of the Sox family transcription factors, is closely associated with the development of a variety of malignant tumors. This study investigates the expression of Sox9, Wnt1 and Fzd1 in human osteosarcoma tissues and cells and the role of Sox9 in the proliferation of human osteosarcoma cells. Immunohistochemical analyses for Sox9, Wnt1, Fzd1, and Ki-67 proteins were performed in human primary osteosarcoma tissues from 48 patients. The small interfering RNA (siRNA) of Sox9 was transfected into human osteosarcoma MG63 cells. At 24 and 48 h after transfection with Sox9 siRNA, the expression of Wnt1 and Fzd1 was analyzed by RT-qPCR, Western blot, and immunofluorescence techniques. Cell proliferation was assayed by CCK-8 method, and Ki-67 protein expression was analyzed by Western blot. Results showed that the expressions of Sox9, Wnt1, Fzd1, and Ki-67 proteins in human osteosarcoma tissues were higher than those in the adjacent non-cancerous tissues. Hyperexpressions of Sox9, Wnt1, Fzd1, and Ki-67 proteins occurred more frequently in human osteosarcoma tissues with an advanced clinical stage (IIb/III). Sox9 siRNA reduced both mRNA and protein expression levels of Wnt1 and Fzd1, which result in the distinct inhibition of MG63 cell proliferation. Our study suggests that Sox9 siRNA inhibits the proliferation capability of human osteosarcoma cells by down-regulating the expression of Wnt1 and its receptor Fzd1, which may provide new gene targets for the clinical treatment of osteosarcoma.

[1]  E. Martinelli,et al.  Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness. , 2014, Gene.

[2]  Yu Cai,et al.  Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic , 2014, Journal of cellular biochemistry.

[3]  A. Rashid,et al.  SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. , 2014, Human pathology.

[4]  W. Park,et al.  Aberrant expression of SOX9 is associated with gastrokine 1 inactivation in gastric cancers , 2014, Gastric Cancer.

[5]  Chih-Hsin Tang,et al.  Ras activation mediates WISP-1-induced increases in cell motility and matrix metalloproteinase expression in human osteosarcoma. , 2013, Cellular signalling.

[6]  Haibo Zhu,et al.  Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients’ prognosis , 2013, Diagnostic Pathology.

[7]  T. He,et al.  The E-F Hand Calcium-Binding Protein S100A4 Regulates the Proliferation, Survival and Differentiation Potential of Human Osteosarcoma Cells , 2013, Cellular Physiology and Biochemistry.

[8]  Olaf Wolkenhauer,et al.  Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling. , 2013, Cellular signalling.

[9]  L. Puskás,et al.  Hmgb1 can facilitate activation of the matrilin-1 gene promoter by Sox9 and L-Sox5/Sox6 in early steps of chondrogenesis. , 2013, Biochimica et biophysica acta.

[10]  S R Piersma,et al.  Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery , 2013, British Journal of Cancer.

[11]  Xin Wang,et al.  miRNA-9 expression is upregulated in the spinal cord of G93A-SOD1 transgenic mice. , 2013, International journal of clinical and experimental pathology.

[12]  Lijun Lin,et al.  Synergistic relationship between dipeptidyl peptidase IV and neutral endopeptidase expression and the combined prognostic significance in osteosarcoma patients , 2013, Medical Oncology.

[13]  A. Richardson,et al.  SOX9 Regulates Low Density Lipoprotein Receptor-related Protein 6 (LRP6) and T-cell Factor 4 (TCF4) Expression and Wnt/β-catenin Activation in Breast Cancer* , 2013, The Journal of Biological Chemistry.

[14]  Thomas H. Leung,et al.  Down-regulation of Sox7 is associated with aberrant activation of Wnt/β-catenin signaling in endometrial cancer , 2012, Oncotarget.

[15]  Xin Wang,et al.  Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice , 2012, Neurological research.

[16]  Xin Wang,et al.  Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. , 2012, Biochemical and biophysical research communications.

[17]  Baoan Ma,et al.  MicroRNA-34a Inhibits the Proliferation and Metastasis of Osteosarcoma Cells Both In Vitro and In Vivo , 2012, PloS one.

[18]  X. Zi,et al.  The Wnt signaling pathway: implications for therapy in osteosarcoma , 2011, Expert review of anticancer therapy.

[19]  R. Lovell-Badge,et al.  Sex determination and the control of Sox9 expression in mammals , 2011, The FEBS journal.

[20]  V. Harley,et al.  Acquisition of SOX transcription factor specificity through protein-protein interaction, modulation of Wnt signalling and post-translational modification. , 2010, The international journal of biochemistry & cell biology.

[21]  A. Zorn,et al.  Interactions between SOX factors and Wnt/β‐catenin signaling in development and disease , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[22]  L. Topol,et al.  Sox9 Inhibits Wnt Signaling by Promoting β-Catenin Phosphorylation in the Nucleus* , 2009, Journal of Biological Chemistry.

[23]  Aaron M. Zorn,et al.  Sox17 and Sox4 Differentially Regulate β-Catenin/T-Cell Factor Activity and Proliferation of Colon Carcinoma Cells , 2007, Molecular and Cellular Biology.

[24]  R. Kist,et al.  SOX9 is required for maintenance of the pancreatic progenitor cell pool , 2007, Proceedings of the National Academy of Sciences.

[25]  Kozo Nakamura,et al.  The canonical Wnt signaling pathway promotes chondrocyte differentiation in a Sox9-dependent manner. , 2005, Biochemical and biophysical research communications.

[26]  J. Healey,et al.  Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. , 2004, Cancer research.

[27]  A. Huvos,et al.  Expression of LDL receptor‐related protein 5 (LRP5) as a novel marker for disease progression in high‐grade osteosarcoma , 2004, International journal of cancer.

[28]  A. Montag,et al.  Cytoplasmic and/or nuclear accumulation of the β‐catenin protein is a frequent event in human osteosarcoma , 2002, International journal of cancer.

[29]  R. Teasdale,et al.  Twenty pairs of sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. , 2002, Developmental cell.

[30]  N. Perrimon,et al.  The Promise and Perils of Wnt Signaling Through β-Catenin , 2002, Science.

[31]  N. Perrimon,et al.  The promise and perils of Wnt signaling through beta-catenin. , 2002, Science.

[32]  Sahar Mansour,et al.  Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene , 1994, Nature.